Best Practice Approaches in Executing Post Approval Programs

Publish Date:
September 17, 2015
Alexandra Adams, Ph.D., Dip. Clin.Sci. Hon FICR, Director, Late Phase

Late phase research is an increasingly critical component of the overall drug development plan. But post-approval studies, often referred to simply as Phase IV, fall into a broad spectrum of research types, requiring different approaches to study execution. This webinar will demonstrate best practices for post-approval research, review the differences between interventional and non-interventional studies (NIS) and examine the reasons for various operational strategies.